Not sure why you bother bruv, you seem to not have the slightest clue. In other news, looking for a re-entry soon, and price is coming back to my last buy in!
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025